Sir William Dunn School of Pathology, University of Oxford, Oxford, U.K.
Biochem Soc Trans. 2023 Jun 28;51(3):995-1008. doi: 10.1042/BST20220749.
ADP-ribosylation is a post-translational modification involved in DNA damage response (DDR). In higher organisms it is synthesised by PARP 1-3, DNA strand break sensors. Recent advances have identified serine residues as the most common targets for ADP-ribosylation during DDR. To ADP-ribosylate serine, PARPs require an accessory factor, HPF1 which completes the catalytic domain. Through ADP-ribosylation, PARPs recruit a variety of factors to the break site and control their activities. However, the timely removal of ADP-ribosylation is also key for genome stability and is mostly performed by two hydrolases: PARG and ARH3. Here, we describe the key writers, readers and erasers of ADP-ribosylation and their contribution to the mounting of the DDR. We also discuss the use of PARP inhibitors in cancer therapy and the ways to tackle PARPi treatment resistance.
ADP-核糖基化是一种参与 DNA 损伤反应 (DDR) 的翻译后修饰。在高等生物中,它由 PARP1-3 合成,PARP1-3 是 DNA 链断裂传感器。最近的研究进展确定丝氨酸残基是 DDR 期间 ADP-核糖基化的最常见靶标。为了对丝氨酸进行 ADP-核糖基化,PARPs 需要一种辅助因子 HPF1 来完成催化结构域。通过 ADP-核糖基化,PARPs 将各种因子招募到断裂部位并控制它们的活性。然而,ADP-核糖基化的及时去除对基因组稳定性也很关键,主要由两种水解酶:PARG 和 ARH3 来完成。在这里,我们描述了 ADP-核糖基化的关键写入器、读取器和擦除器及其对 DDR 的贡献。我们还讨论了 PARP 抑制剂在癌症治疗中的应用以及克服 PARPi 治疗耐药性的方法。